Global Neurodegenerative Disease Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neurodegenerative Disease Market Size 2017-2028

2.1.2 Neurodegenerative Disease Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Neurodegenerative Disease Segment by Type

2.2.1 NMDA

2.2.2 SSRIs

2.2.3 Dopamine Inhibitors

2.3 Neurodegenerative Disease Market Size by Type

2.3.1 Neurodegenerative Disease Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Neurodegenerative Disease Market Size Market Share by Type (2017-2022)

2.4 Neurodegenerative Disease Segment by Application

2.4.1 Parkinson’s Disease

2.4.2 Huntington Disease

2.4.3 Amyotrophic Lateral Sclerosis

2.4.4 Alzheimer’s Disease

2.5 Neurodegenerative Disease Market Size by Application

2.5.1 Neurodegenerative Disease Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Neurodegenerative Disease Market Size Market Share by Application (2017-2022)

3 Neurodegenerative Disease Market Size by Player

3.1 Neurodegenerative Disease Market Size Market Share by Players

3.1.1 Global Neurodegenerative Disease Revenue by Players (2020-2022)

3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2020-2022)

3.2 Global Neurodegenerative Disease Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Neurodegenerative Disease by Regions

4.1 Neurodegenerative Disease Market Size by Regions (2017-2022)

4.2 Americas Neurodegenerative Disease Market Size Growth (2017-2022)

4.3 APAC Neurodegenerative Disease Market Size Growth (2017-2022)

4.4 Europe Neurodegenerative Disease Market Size Growth (2017-2022)

4.5 Middle East & Africa Neurodegenerative Disease Market Size Growth (2017-2022)

5 Americas

5.1 Americas Neurodegenerative Disease Market Size by Country (2017-2022)

5.2 Americas Neurodegenerative Disease Market Size by Type (2017-2022)

5.3 Americas Neurodegenerative Disease Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neurodegenerative Disease Market Size by Region (2017-2022)

6.2 APAC Neurodegenerative Disease Market Size by Type (2017-2022)

6.3 APAC Neurodegenerative Disease Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neurodegenerative Disease by Country (2017-2022)

7.2 Europe Neurodegenerative Disease Market Size by Type (2017-2022)

7.3 Europe Neurodegenerative Disease Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neurodegenerative Disease by Region (2017-2022)

8.2 Middle East & Africa Neurodegenerative Disease Market Size by Type (2017-2022)

8.3 Middle East & Africa Neurodegenerative Disease Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Neurodegenerative Disease Market Forecast

10.1 Global Neurodegenerative Disease Forecast by Regions (2023-2028)

10.1.1 Global Neurodegenerative Disease Forecast by Regions (2023-2028)

10.1.2 Americas Neurodegenerative Disease Forecast

10.1.3 APAC Neurodegenerative Disease Forecast

10.1.4 Europe Neurodegenerative Disease Forecast

10.1.5 Middle East & Africa Neurodegenerative Disease Forecast

10.2 Americas Neurodegenerative Disease Forecast by Country (2023-2028)

10.2.1 United States Neurodegenerative Disease Market Forecast

10.2.2 Canada Neurodegenerative Disease Market Forecast

10.2.3 Mexico Neurodegenerative Disease Market Forecast

10.2.4 Brazil Neurodegenerative Disease Market Forecast

10.3 APAC Neurodegenerative Disease Forecast by Region (2023-2028)

10.3.1 China Neurodegenerative Disease Market Forecast

10.3.2 Japan Neurodegenerative Disease Market Forecast

10.3.3 Korea Neurodegenerative Disease Market Forecast

10.3.4 Southeast Asia Neurodegenerative Disease Market Forecast

10.3.5 India Neurodegenerative Disease Market Forecast

10.3.6 Australia Neurodegenerative Disease Market Forecast

10.4 Europe Neurodegenerative Disease Forecast by Country (2023-2028)

10.4.1 Germany Neurodegenerative Disease Market Forecast

10.4.2 France Neurodegenerative Disease Market Forecast

10.4.3 UK Neurodegenerative Disease Market Forecast

10.4.4 Italy Neurodegenerative Disease Market Forecast

10.4.5 Russia Neurodegenerative Disease Market Forecast

10.5 Middle East & Africa Neurodegenerative Disease Forecast by Region (2023-2028)

10.5.1 Egypt Neurodegenerative Disease Market Forecast

10.5.2 South Africa Neurodegenerative Disease Market Forecast

10.5.3 Israel Neurodegenerative Disease Market Forecast

10.5.4 Turkey Neurodegenerative Disease Market Forecast

10.5.5 GCC Countries Neurodegenerative Disease Market Forecast

10.6 Global Neurodegenerative Disease Forecast by Type (2023-2028)

10.7 Global Neurodegenerative Disease Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Novartis

11.1.1 Novartis Company Information

11.1.2 Novartis Neurodegenerative Disease Product Offered

11.1.3 Novartis Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Novartis Main Business Overview

11.1.5 Novartis Latest Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Neurodegenerative Disease Product Offered

11.2.3 Pfizer Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Main Business Overview

11.2.5 Pfizer Latest Developments

11.3 Merck Serono

11.3.1 Merck Serono Company Information

11.3.2 Merck Serono Neurodegenerative Disease Product Offered

11.3.3 Merck Serono Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Merck Serono Main Business Overview

11.3.5 Merck Serono Latest Developments

11.4 Biogen Idec

11.4.1 Biogen Idec Company Information

11.4.2 Biogen Idec Neurodegenerative Disease Product Offered

11.4.3 Biogen Idec Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Biogen Idec Main Business Overview

11.4.5 Biogen Idec Latest Developments

11.5 TEVA

11.5.1 TEVA Company Information

11.5.2 TEVA Neurodegenerative Disease Product Offered

11.5.3 TEVA Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 TEVA Main Business Overview

11.5.5 TEVA Latest Developments

11.6 UCB

11.6.1 UCB Company Information

11.6.2 UCB Neurodegenerative Disease Product Offered

11.6.3 UCB Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 UCB Main Business Overview

11.6.5 UCB Latest Developments

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Information

11.7.2 Boehringer Ingelheim Neurodegenerative Disease Product Offered

11.7.3 Boehringer Ingelheim Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Boehringer Ingelheim Main Business Overview

11.7.5 Boehringer Ingelheim Latest Developments

11.8 Sanofi

11.8.1 Sanofi Company Information

11.8.2 Sanofi Neurodegenerative Disease Product Offered

11.8.3 Sanofi Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Sanofi Main Business Overview

11.8.5 Sanofi Latest Developments

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Company Information

11.9.2 GlaxoSmithKline Neurodegenerative Disease Product Offered

11.9.3 GlaxoSmithKline Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 GlaxoSmithKline Main Business Overview

11.9.5 GlaxoSmithKline Latest Developments

11.10 Livzon Pharmaceutical

11.10.1 Livzon Pharmaceutical Company Information

11.10.2 Livzon Pharmaceutical Neurodegenerative Disease Product Offered

11.10.3 Livzon Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Livzon Pharmaceutical Main Business Overview

11.10.5 Livzon Pharmaceutical Latest Developments

11.11 Haisco Pharmaceutical

11.11.1 Haisco Pharmaceutical Company Information

11.11.2 Haisco Pharmaceutical Neurodegenerative Disease Product Offered

11.11.3 Haisco Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Haisco Pharmaceutical Main Business Overview

11.11.5 Haisco Pharmaceutical Latest Developments

11.12 Jingxin Pharmaceutical

11.12.1 Jingxin Pharmaceutical Company Information

11.12.2 Jingxin Pharmaceutical Neurodegenerative Disease Product Offered

11.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Jingxin Pharmaceutical Main Business Overview

11.12.5 Jingxin Pharmaceutical Latest Developments

11.13 Dongcheng Biochemicals

11.13.1 Dongcheng Biochemicals Company Information

11.13.2 Dongcheng Biochemicals Neurodegenerative Disease Product Offered

11.13.3 Dongcheng Biochemicals Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Dongcheng Biochemicals Main Business Overview

11.13.5 Dongcheng Biochemicals Latest Developments

11.14 Hisun Pharmaceutical

11.14.1 Hisun Pharmaceutical Company Information

11.14.2 Hisun Pharmaceutical Neurodegenerative Disease Product Offered

11.14.3 Hisun Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Hisun Pharmaceutical Main Business Overview

11.14.5 Hisun Pharmaceutical Latest Developments

11.15 Luye Pharma

11.15.1 Luye Pharma Company Information

11.15.2 Luye Pharma Neurodegenerative Disease Product Offered

11.15.3 Luye Pharma Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Luye Pharma Main Business Overview

11.15.5 Luye Pharma Latest Developments

11.16 Ark Pharmaceutical

11.16.1 Ark Pharmaceutical Company Information

11.16.2 Ark Pharmaceutical Neurodegenerative Disease Product Offered

11.16.3 Ark Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Ark Pharmaceutical Main Business Overview

11.16.5 Ark Pharmaceutical Latest Developments

11.17 Kanghong Pharmaceutical

11.17.1 Kanghong Pharmaceutical Company Information

11.17.2 Kanghong Pharmaceutical Neurodegenerative Disease Product Offered

11.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Kanghong Pharmaceutical Main Business Overview

11.17.5 Kanghong Pharmaceutical Latest Developments

11.18 Huahai Pharmaceutical

11.18.1 Huahai Pharmaceutical Company Information

11.18.2 Huahai Pharmaceutical Neurodegenerative Disease Product Offered

11.18.3 Huahai Pharmaceutical Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Huahai Pharmaceutical Main Business Overview

11.18.5 Huahai Pharmaceutical Latest Developments

11.19 BORA PHARMACEUTICALS

11.19.1 BORA PHARMACEUTICALS Company Information

11.19.2 BORA PHARMACEUTICALS Neurodegenerative Disease Product Offered

11.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 BORA PHARMACEUTICALS Main Business Overview

11.19.5 BORA PHARMACEUTICALS Latest Developments

12 Research Findings and Conclusion

Table 1. Neurodegenerative Disease Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of NMDA

Table 3. Major Players of SSRIs

Table 4. Major Players of Dopamine Inhibitors

Table 5. Neurodegenerative Disease Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Neurodegenerative Disease Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Neurodegenerative Disease Market Size Market Share by Type (2017-2022)

Table 8. Neurodegenerative Disease Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Neurodegenerative Disease Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Neurodegenerative Disease Market Size Market Share by Application (2017-2022)

Table 11. Global Neurodegenerative Disease Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Neurodegenerative Disease Revenue Market Share by Player (2020-2022)

Table 13. Neurodegenerative Disease Key Players Head office and Products Offered

Table 14. Neurodegenerative Disease Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Neurodegenerative Disease Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Neurodegenerative Disease Market Size Market Share by Regions (2017-2022)

Table 19. Americas Neurodegenerative Disease Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Neurodegenerative Disease Market Size Market Share by Country (2017-2022)

Table 21. Americas Neurodegenerative Disease Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Neurodegenerative Disease Market Size Market Share by Type (2017-2022)

Table 23. Americas Neurodegenerative Disease Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Neurodegenerative Disease Market Size Market Share by Application (2017-2022)

Table 25. APAC Neurodegenerative Disease Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Neurodegenerative Disease Market Size Market Share by Region (2017-2022)

Table 27. APAC Neurodegenerative Disease Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Neurodegenerative Disease Market Size Market Share by Type (2017-2022)

Table 29. APAC Neurodegenerative Disease Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Neurodegenerative Disease Market Size Market Share by Application (2017-2022)

Table 31. Europe Neurodegenerative Disease Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Neurodegenerative Disease Market Size Market Share by Country (2017-2022)

Table 33. Europe Neurodegenerative Disease Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Neurodegenerative Disease Market Size Market Share by Type (2017-2022)

Table 35. Europe Neurodegenerative Disease Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Neurodegenerative Disease Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Neurodegenerative Disease Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Neurodegenerative Disease Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Neurodegenerative Disease Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease

Table 44. Key Market Challenges & Risks of Neurodegenerative Disease

Table 45. Key Industry Trends of Neurodegenerative Disease

Table 46. Global Neurodegenerative Disease Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Neurodegenerative Disease Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Neurodegenerative Disease Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Neurodegenerative Disease Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Neurodegenerative Disease Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Neurodegenerative Disease Market Size Market Share Forecast by Application (2023-2028)

Table 52. Novartis Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 53. Novartis Neurodegenerative Disease Product Offered

Table 54. Novartis Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Novartis Main Business

Table 56. Novartis Latest Developments

Table 57. Pfizer Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 58. Pfizer Neurodegenerative Disease Product Offered

Table 59. Pfizer Main Business

Table 60. Pfizer Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Pfizer Latest Developments

Table 62. Merck Serono Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 63. Merck Serono Neurodegenerative Disease Product Offered

Table 64. Merck Serono Main Business

Table 65. Merck Serono Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Merck Serono Latest Developments

Table 67. Biogen Idec Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 68. Biogen Idec Neurodegenerative Disease Product Offered

Table 69. Biogen Idec Main Business

Table 70. Biogen Idec Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Biogen Idec Latest Developments

Table 72. TEVA Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 73. TEVA Neurodegenerative Disease Product Offered

Table 74. TEVA Main Business

Table 75. TEVA Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. TEVA Latest Developments

Table 77. UCB Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 78. UCB Neurodegenerative Disease Product Offered

Table 79. UCB Main Business

Table 80. UCB Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. UCB Latest Developments

Table 82. Boehringer Ingelheim Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 83. Boehringer Ingelheim Neurodegenerative Disease Product Offered

Table 84. Boehringer Ingelheim Main Business

Table 85. Boehringer Ingelheim Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Boehringer Ingelheim Latest Developments

Table 87. Sanofi Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 88. Sanofi Neurodegenerative Disease Product Offered

Table 89. Sanofi Main Business

Table 90. Sanofi Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Sanofi Latest Developments

Table 92. GlaxoSmithKline Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 93. GlaxoSmithKline Neurodegenerative Disease Product Offered

Table 94. GlaxoSmithKline Main Business

Table 95. GlaxoSmithKline Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. GlaxoSmithKline Latest Developments

Table 97. Livzon Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 98. Livzon Pharmaceutical Neurodegenerative Disease Product Offered

Table 99. Livzon Pharmaceutical Main Business

Table 100. Livzon Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Livzon Pharmaceutical Latest Developments

Table 102. Haisco Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 103. Haisco Pharmaceutical Neurodegenerative Disease Product Offered

Table 104. Haisco Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Haisco Pharmaceutical Main Business

Table 106. Haisco Pharmaceutical Latest Developments

Table 107. Jingxin Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 108. Jingxin Pharmaceutical Neurodegenerative Disease Product Offered

Table 109. Jingxin Pharmaceutical Main Business

Table 110. Jingxin Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Jingxin Pharmaceutical Latest Developments

Table 112. Dongcheng Biochemicals Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 113. Dongcheng Biochemicals Neurodegenerative Disease Product Offered

Table 114. Dongcheng Biochemicals Main Business

Table 115. Dongcheng Biochemicals Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Dongcheng Biochemicals Latest Developments

Table 117. Hisun Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 118. Hisun Pharmaceutical Neurodegenerative Disease Product Offered

Table 119. Hisun Pharmaceutical Main Business

Table 120. Hisun Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Hisun Pharmaceutical Latest Developments

Table 122. Luye Pharma Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 123. Luye Pharma Neurodegenerative Disease Product Offered

Table 124. Luye Pharma Main Business

Table 125. Luye Pharma Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Luye Pharma Latest Developments

Table 127. Ark Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 128. Ark Pharmaceutical Neurodegenerative Disease Product Offered

Table 129. Ark Pharmaceutical Main Business

Table 130. Ark Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. Ark Pharmaceutical Latest Developments

Table 132. Kanghong Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 133. Kanghong Pharmaceutical Neurodegenerative Disease Product Offered

Table 134. Kanghong Pharmaceutical Main Business

Table 135. Kanghong Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 136. Kanghong Pharmaceutical Latest Developments

Table 137. Huahai Pharmaceutical Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 138. Huahai Pharmaceutical Neurodegenerative Disease Product Offered

Table 139. Huahai Pharmaceutical Main Business

Table 140. Huahai Pharmaceutical Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 141. Huahai Pharmaceutical Latest Developments

Table 142. BORA PHARMACEUTICALS Details, Company Type, Neurodegenerative Disease Area Served and Its Competitors

Table 143. BORA PHARMACEUTICALS Neurodegenerative Disease Product Offered

Table 144. BORA PHARMACEUTICALS Main Business

Table 145. BORA PHARMACEUTICALS Neurodegenerative Disease Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 146. BORA PHARMACEUTICALS Latest Developments

List of Figures

Figure 1. Neurodegenerative Disease Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Neurodegenerative Disease Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Neurodegenerative Disease Market Size Market Share by Type in 2021

Figure 7. Neurodegenerative Disease in Parkinson’s Disease

Figure 8. Global Neurodegenerative Disease Market: Parkinson’s Disease (2017-2022) & ($ Millions)

Figure 9. Neurodegenerative Disease in Huntington Disease

Figure 10. Global Neurodegenerative Disease Market: Huntington Disease (2017-2022) & ($ Millions)

Figure 11. Neurodegenerative Disease in Amyotrophic Lateral Sclerosis

Figure 12. Global Neurodegenerative Disease Market: Amyotrophic Lateral Sclerosis (2017-2022) & ($ Millions)

Figure 13. Neurodegenerative Disease in Alzheimer’s Disease

Figure 14. Global Neurodegenerative Disease Market: Alzheimer’s Disease (2017-2022) & ($ Millions)

Figure 15. Global Neurodegenerative Disease Market Size Market Share by Application in 2021

Figure 16. Global Neurodegenerative Disease Revenue Market Share by Player in 2021

Figure 17. Global Neurodegenerative Disease Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Neurodegenerative Disease Market Size 2017-2022 ($ Millions)

Figure 19. APAC Neurodegenerative Disease Market Size 2017-2022 ($ Millions)

Figure 20. Europe Neurodegenerative Disease Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Neurodegenerative Disease Market Size 2017-2022 ($ Millions)

Figure 22. Americas Neurodegenerative Disease Value Market Share by Country in 2021

Figure 23. Americas Neurodegenerative Disease Consumption Market Share by Type in 2021

Figure 24. Americas Neurodegenerative Disease Market Size Market Share by Application in 2021

Figure 25. United States Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Neurodegenerative Disease Market Size Market Share by Region in 2021

Figure 30. APAC Neurodegenerative Disease Market Size Market Share by Application in 2021

Figure 31. China Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Neurodegenerative Disease Market Size Market Share by Country in 2021

Figure 38. Europe Neurodegenerative Disease Market Size Market Share by Type in 2021

Figure 39. Europe Neurodegenerative Disease Market Size Market Share by Application in 2021

Figure 40. Germany Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Neurodegenerative Disease Market Size Market Share by Application in 2021

Figure 48. Egypt Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Neurodegenerative Disease Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 54. APAC Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 55. Europe Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 57. United States Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 58. Canada Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 61. China Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 62. Japan Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 63. Korea Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 65. India Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 66. Australia Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 67. Germany Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 68. France Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 69. UK Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 70. Italy Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 71. Russia Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 72. Spain Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 75. Israel Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Neurodegenerative Disease Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Neurodegenerative Disease Market Size 2023-2028 ($ Millions)